We will join the 5th RNA-Seq Summit in San Francisco. This time we are not only showcasing our advanced RNA sequencing bioinformatics solutions, but also presenting our innovative assay technology.
Come and meet our scientists to see how our RNA sequencing solutions can maximize the value of your research, empowered by CLC Genomics Workbench, Ingenuity Pathway Analysis (IPA), and QIAseq Targeted RNA Panels for gene expression profiling.
Sign up online for the workshop now!
We’re also hosting a 4-hour workshop. This workshop will include in-depth coverage of the bioinformatics solutions from QIAGEN used to analyze and interpret whole transcriptome and targeted RNA sequencing results from pre-treatment mRNAs of patients with advanced metastatic melanoma, and with respect to their subsequent immunotherapy treatment outcomes. We will show how to optimize transcriptome data and will provide details on the biological signatures that determine non-responder versus responder status using Ingenuity Pathway Analysis (IPA).
Topic: Understanding innate resistance to anti-PD-1 therapy in melanoma through transcriptomics
Date: 9 a.m. – 1 p.m., April 25, 2017
– Dr. Jean-Noel Billaud, Senior Principal Scientist – QIAGEN Bioinformatics
– Dr. Samuel Rulli, Global Product Manager – QIAGEN
Remember to register now to reserve your spot: sign up here
We look forward to seeing you in San Francisco from April 25–27!
© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers